Status:
COMPLETED
Risk Factors for Recurrence of Thrombosis or Thrombotic Extension, in the Event of Acute Non-cirrhotic Portal Vein Thrombosis Secondary to a Local Cause.
Lead Sponsor:
University Hospital, Caen
Conditions:
Portal Vein Thrombosis
Local Cause
Eligibility:
All Genders
18+ years
Brief Summary
In case of acute portal vein thrombosis (PVT) prothrombotic factors are identified in about 60% of cases, while a local condition is present in 30% of cases. Prothrombotic factors may indicate a long ...
Eligibility Criteria
Inclusion
- acute portal thrombosis segmental or truncal, diagnosed in the context of a local inflammatory, infectious, trauma or abdominal surgery cause, dating from less than 3 months.
- patients already included in european cohort ENVIE-VALDIG
Exclusion
- liver cirrhosis
- liver, biliary or pancreatic neoplasia
- thrombosis limited to mesenteric vein, splenic vein or splenomesaraic confluence
- cavernoma or Budd-Chiari syndrom
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT05360641
Start Date
August 1 2019
End Date
March 31 2022
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu de Caen
Caen, Calvados, France, 14033